MannKind Co. (NASDAQ:MNKD – Get Free Report) has received a consensus rating of “Buy” from the eight ratings firms that are ...

Proficio Capital Partners LLC acquired a new stake in shares of MannKind Co. (NASDAQ:MNKD – Free Report) in the fourth ...

The question is surprisingly hard to answer. For example, a 10% tariff on shoes from China would raise their sticker price 4% or so, but on wine or olive oil from Italy, almost 10%.

Last week, you might have seen that MannKind Corporation (NASDAQ:MNKD) released its full-year result to the market. The early response was not positive, with shares down 7.3% to US$5.34 in the past ...

MannKind’s stock has fluctuated due to Tyvaso DPI’s Q4 underperformance and competitive pressures, but it remains a key revenue driver for future profitability and R&D funding. Tyvaso DPI’s ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sarepta Therapeutics (SRPT – Research Report), ...

Before you buy stock in MannKind, consider this ... partially offset by improved growth-to-net adjustments, and increased price. As a reminder, as of the fourth quarter of 2024, the sales force ...

MannKind (MNKD) reported $76.78 million in revenue ... analysts estimated about them helps investors better project a stock's price performance. Here is how MannKind performed in the just reported ...